Schedule 13D ownership disclosure
ESSA PHARMA INC
Security class unavailable · CUSIP: 29668H104
Event date: 2018-01-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 30.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-196616
- Form type
- SC 13D
- Filer
- Clarus Lifesciences III, L.P.
- CIK
- CIK 1597143
- Filed
- Jun 19, 2018
- Reporting period
- Jan 04, 2018
- Description
- Schedule 13D beneficial ownership